How do we treat persistent epistaxis (nosebleed) in children that doesn't stop bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Persistent Epistaxis in Children

For persistent epistaxis in children that continues despite initial measures, apply firm sustained nasal compression to the lower third of the nose for at least 5 minutes, and if bleeding persists, use topical vasoconstrictors followed by nasal packing with resorbable materials if the child has bleeding risk factors. 1

Immediate Management Algorithm

Step 1: Proper Nasal Compression (First-Line Treatment)

  • Position the child sitting upright with head tilted slightly forward to prevent blood from entering the airway or being swallowed 2, 3
  • Apply firm, sustained digital compression to the soft lower third of the nose for a minimum of 5 minutes without interruption 1
  • The compression must be continuous—do not check if bleeding has stopped before 5 minutes, as this is a common pitfall that leads to treatment failure 2
  • Have the child breathe through their mouth and spit out any blood rather than swallowing it 2, 3
  • Compression alone controls the majority of pediatric epistaxis cases, including those presenting to emergency departments 1, 2

Step 2: Add Topical Vasoconstrictors if Compression Fails

  • If bleeding continues after 5 minutes of compression, clear clots from the nose and apply a topical vasoconstrictor such as oxymetazoline (Afrin) or phenylephrine 1, 3
  • Spray 2 times into the bleeding nostril, then resume firm compression for an additional 5 minutes 2
  • Vasoconstrictors can be applied via nasal spray or cotton pledgets soaked with the medication inserted into the nose 1
  • This approach stops bleeding in 65-75% of cases treated in emergency departments 3, 4
  • While obtaining history during compression, ask specifically about: medications (especially anticoagulants/antiplatelets), personal history of bleeding disorders, family history of bleeding disorders, and recent nasal procedures 1

Step 3: Nasal Packing for Refractory Bleeding

  • If bleeding precludes identification of a bleeding site despite nasal compression and vasoconstrictors, proceed to nasal packing 1
  • For children with suspected bleeding disorders or those on anticoagulation/antiplatelet medications, use resorbable packing materials specifically 1, 2
  • Resorbable packing reduces the likelihood of additional bleeding when removed compared to non-resorbable materials 1
  • Non-resorbable options include petroleum jelly-impregnated gauze, PVA nasal tampons (Merocel), or balloon systems (Rapid-Rhino) 4
  • Newer hemostatic materials like hemostatic gauzes (Surgicel), thrombin matrix (Floseal), gelatin sponge (Spongostan), or fibrin glue are more effective with fewer complications 4

Indications for More Aggressive Management

Proceed beyond compression and packing when: 1

  • Bleeding fails to stop or slow with compression
  • The nosebleed is judged to be life-threatening
  • Continued bleeding occurs out the nose or into the posterior pharynx during compression (suggests posterior bleeding site)
  • Bleeding duration exceeds 30 minutes over a 24-hour period 2
  • The child shows signs of hemodynamic instability such as tachycardia or hypotension 2

Advanced Treatment Options (Specialist Consultation Required)

Nasal Cautery

  • Requires anesthesia of the bleeding site with topical lidocaine or tetracaine applied via spray or cotton pledgets 1
  • Restrict cautery application only to the active or suspected bleeding site(s) to minimize risk of septal perforation 1
  • Young children and uncooperative patients may require sedation or general anesthesia 1
  • Electrocautery is more effective than chemical cauterization, with recurrence rates of 14.5% versus 35.1% 3, 4
  • Bilateral cautery should be used selectively and cautiously to minimize septal perforation risk 1

Tranexamic Acid (Emerging Option)

  • Topical tranexamic acid (TXA) has shown higher rates of acute bleeding control compared to anterior nasal packing in emergency department studies 1
  • However, the guideline notes that additional study is needed to fully understand indications and efficacy, as most studies are of moderate quality 1

Prevention of Recurrence

Once bleeding is controlled: 2, 3

  • Apply moisturizing or lubricating agents such as petroleum jelly to the nasal mucosa
  • Use saline nasal sprays regularly to keep nasal mucosa moist
  • Consider humidifier use, especially in dry environments
  • Instruct the child to avoid nose picking or rubbing to allow healing

Critical Pitfalls to Avoid

  • Insufficient compression time: Must maintain pressure for full 5 minutes minimum without checking 2
  • Premature checking: Interrupting compression to see if bleeding stopped restarts the process 2
  • Using non-resorbable packing in high-risk patients: Children with bleeding disorders or on anticoagulants require resorbable materials 1, 2
  • Bilateral cautery without caution: Increases risk of septal perforation 1
  • Neglecting prevention: Failing to address nasal mucosa dryness leads to recurrent episodes 2

When to Seek Specialist Consultation

Refer to otolaryngology when: 2, 3

  • Bleeding persists after 15 minutes of continuous proper compression
  • The child experiences dizziness from blood loss
  • Nasal packing fails to control bleeding
  • Recurrent epistaxis occurs despite preventive measures
  • Endoscopic evaluation, arterial ligation, or embolization may be needed

Special Pediatric Considerations

  • Most pediatric epistaxis is mild and self-limited, with only 5% requiring cautery or packing and 8% requiring more intensive intervention 5
  • Risk factors for moderate epistaxis in children include older age, prior ED visit within 72 hours, and antiplatelet medication use 5
  • Risk factors for severe epistaxis include bleeding disorders, nasal procedures within 30 days, and anticoagulation use 5
  • Bleeding duration over 30 minutes prior to arrival is associated with both moderate and severe epistaxis 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Epistaxis in Patients on Ozempic (Semaglutide)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Epistaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epistaxis Treatment Options: Literature Review.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2023

Related Questions

What is the best course of action for a patient presenting with a 30-minute nosebleed, history of nasal congestion, pallor, and anxiety?
What is the benefit of using Vaseline (petroleum jelly) for epistaxis (nosebleeds)?
What is the first line of management for a patient presenting with right-sided epistaxis (nosebleed) that began approximately 30 minutes ago?
What is not a reasonable next step for treating epistaxis (nosebleed) that hasn't responded to direct pressure, between nephron (kidney unit) posterior nasal packing, interior nasal packing, or application of silver nitrate?
What are the common causes, best treatment, and preventative measures for epistaxis (nosebleed) in a 2.5-year-old child with no history of excessive bruising or bleeding?
What are the indications for hospital admission in cases of hypothyroidism (underactive thyroid gland)?
What are the primary nutritional risk factors for a pregnant patient with a body mass index (BMI) of 32.1 kg/m^2, iron deficiency anemia, and limited access to nutritious food?
How does the Infectious Diseases Society of America (IDSA) classify the severity of skin and soft tissue infections?
What are the sensitivities of chromogranin A (Chromogranin A), serum 5-HIAA (5-Hydroxyindoleacetic Acid), and fasting serum serotonin levels for diagnosing carcinoid syndrome?
What medications can be given intravenously (IV) for managing secretions?
What is the management approach for a patient with a reactive Hepatitis C (HCV) antibody test and a non-reactive Hepatitis C RNA test?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.